Home › Trial NCT05780294
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC
- Trial IDNCT05780294
- StatusNot Yet Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorSun Yat-sen University
- Enrollment132
- Start date2023-04-01
- ConditionsNasopharyngeal Carcinoma · Leucogen · Chemotherapy · Myelosuppression
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.